Estradiol patch. The safest first-line systemic HRT for most women in menopause.

Transdermal estradiol — the patch — delivers estrogen through the skin, bypassing the liver. That single fact is why most major guideline bodies (NAMS, Endocrine Society, BMS) prefer it as first-line systemic HRT: lower clot risk, lower stroke risk, and no impact on liver-made clotting factors.

Why transdermal is preferred over oral

Oral estradiol passes through the liver before reaching circulation (first-pass metabolism). That liver pass increases production of clotting factors and slightly raises VTE and stroke risk. Transdermal estradiol skips the liver — published data (BMJ 2019) show no excess VTE risk at standard doses. This is the key safety argument that has driven international guidelines to recommend transdermal first-line for women over 60, those with elevated cardiovascular risk, migraine with aura, obesity, or any prior clotting event.

Available brands and forms in the U.S.

How to apply

• Apply to clean, dry, lotion-free skin on the lower abdomen or upper buttock.
• Rotate sites with each change to prevent irritation.
• Press firmly for 10 seconds. The patch can be worn through showers, swimming, and exercise.
• Never apply to the breast.
• If a patch falls off, reapply or replace; resume the original schedule.

Pairing with progesterone if you have a uterus

Estrogen alone causes endometrial thickening and raises uterine cancer risk. Women with a uterus need a progestogen alongside the patch — typically micronized progesterone (Prometrium) 100-200 mg at bedtime, daily or cyclically.

What to expect — timeline

Hot flashes typically improve within 2-4 weeks. Sleep within 4-6 weeks. Mood, libido, and joint comfort over 8-12 weeks. Vaginal symptoms respond more slowly to systemic patches and often need a local vaginal estrogen for full relief.

Side effects

Skin irritation at the patch site is the most common (rotating sites usually solves it). Breast tenderness, mild nausea, and bloating are common in the first 4-6 weeks and typically settle. Headaches can occur — often improve as the dose stabilizes.

FAQ

Clinical sources

• BMJ — Oral vs transdermal estrogen and VTE risk
• NAMS / The Menopause Society — 2022 Hormone Therapy Position Statement
• ACOG — Hormone Therapy and Menopause
• Endocrine Society — Menopause Clinical Practice Guideline

Related guides

Explore more

• The complete Menopause Guide
• HRT guide cluster
• Free symptom checker
• Pricing

Information on this page is for educational purposes only and is not a substitute for individualized medical advice. Prescription medications require clinical evaluation and provider approval. Individual results vary. This is not an emergency service — if you are experiencing a medical emergency, call 911.